224 related articles for article (PubMed ID: 36162872)
1. α1-Antitrypsin Binds to the Glucocorticoid Receptor with Anti-Inflammatory and Antimycobacterial Significance in Macrophages.
Bai X; Bai A; Tomasicchio M; Hagman JR; Buckle AM; Gupta A; Kadiyala V; Bevers S; Serban KA; Kim K; Feng Z; Spendier K; Hagen G; Fornis L; Griffith DE; Dzieciatkowska M; Sandhaus RA; Gerber AN; Chan ED
J Immunol; 2022 Nov; 209(9):1746-1759. PubMed ID: 36162872
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsin.
Janciauskiene S; Larsson S; Larsson P; Virtala R; Jansson L; Stevens T
Biochem Biophys Res Commun; 2004 Aug; 321(3):592-600. PubMed ID: 15358147
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.
Jonigk D; Al-Omari M; Maegel L; Müller M; Izykowski N; Hong J; Hong K; Kim SH; Dorsch M; Mahadeva R; Laenger F; Kreipe H; Braun A; Shahaf G; Lewis EC; Welte T; Dinarello CA; Janciauskiene S
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15007-12. PubMed ID: 23975926
[TBL] [Abstract][Full Text] [Related]
4. alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
Nita IM; Serapinas D; Janciauskiene SM
Int J Biochem Cell Biol; 2007; 39(6):1165-76. PubMed ID: 17448722
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant α1-antitrypsin Fc-fused (AAT-Fc)protein on the inhibition of inflammatory cytokine production and streptozotocin-induced diabetes.
Lee S; Lee Y; Hong K; Hong J; Bae S; Choi J; Jhun H; Kwak A; Kim E; Jo S; Dinarello CA; Kim S
Mol Med; 2013 May; 19(1):65-71. PubMed ID: 23552726
[TBL] [Abstract][Full Text] [Related]
6. Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of action.
Schuster R; Motola-Kalay N; Baranovski BM; Bar L; Tov N; Stein M; Lewis EC; Ayalon M; Sagiv Y
Cell Immunol; 2020 Oct; 356():104177. PubMed ID: 32795666
[TBL] [Abstract][Full Text] [Related]
7. Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
Ortiz G; Salica JP; Chuluyan EH; Gallo JE
Biol Res; 2014 Nov; 47():58. PubMed ID: 25723058
[TBL] [Abstract][Full Text] [Related]
8. Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β.
Agné A; Richter K; Padberg W; Janciauskiene S; Grau V
Pulm Pharmacol Ther; 2021 Jun; 68():102020. PubMed ID: 33774155
[TBL] [Abstract][Full Text] [Related]
9. Sensitive and specific measurement of alpha
Engelmaier A; Weber A
J Pharm Biomed Anal; 2022 Feb; 209():114476. PubMed ID: 34838346
[TBL] [Abstract][Full Text] [Related]
10. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
[TBL] [Abstract][Full Text] [Related]
11. Divergent effects of alpha1-antitrypsin on neutrophil activation, in vitro.
Janciauskiene S; Zelvyte I; Jansson L; Stevens T
Biochem Biophys Res Commun; 2004 Mar; 315(2):288-96. PubMed ID: 14766206
[TBL] [Abstract][Full Text] [Related]
12. Expanding the clinical indications for α(1)-antitrypsin therapy.
Lewis EC
Mol Med; 2012 Sep; 18(1):957-70. PubMed ID: 22634722
[TBL] [Abstract][Full Text] [Related]
13. Does heart surgery change the capacity of α1-antitrypsin to inhibit the ATP-induced release of monocytic interleukin-1β? A preliminary study.
Agné A; Richter K; Tumpara S; Sauer AL; Beckert F; Wrenger S; Zakrzewicz A; Hecker A; Markmann M; Koch C; Zajonz T; Sander M; Böning A; Padberg W; Janciauskiene S; Grau V
Int Immunopharmacol; 2020 Apr; 81():106297. PubMed ID: 32062078
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015).
Lior Y; Geyra A; Lewis EC
Expert Opin Ther Pat; 2016 May; 26(5):581-9. PubMed ID: 26966859
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1-Antitrypsin Enhances Primary Human Macrophage Immunity Against Non-tuberculous Mycobacteria.
Bai X; Bai A; Honda JR; Eichstaedt C; Musheyev A; Feng Z; Huitt G; Harbeck R; Kosmider B; Sandhaus RA; Chan ED
Front Immunol; 2019; 10():1417. PubMed ID: 31293581
[No Abstract] [Full Text] [Related]
16. High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.
Moreno JA; Ortega-Gomez A; Rubio-Navarro A; Louedec L; Ho-Tin-Noé B; Caligiuri G; Nicoletti A; Levoye A; Plantier L; Meilhac O
Am J Respir Cell Mol Biol; 2014 Oct; 51(4):536-49. PubMed ID: 24787644
[TBL] [Abstract][Full Text] [Related]
17. The lipid ties of α1-antitrypsin: Structural and functional aspects.
Segal L; Lewis EC
Cell Immunol; 2022 May; 375():104528. PubMed ID: 35468329
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.
Krotova K; Marek GW; Wang RL; Aslanidi G; Hoffman BE; Khodayari N; Rouhani FN; Brantly ML
Am J Respir Cell Mol Biol; 2017 Aug; 57(2):238-247. PubMed ID: 28362108
[TBL] [Abstract][Full Text] [Related]
19. YopM of Yersinia enterocolitica specifically interacts with alpha1-antitrypsin without affecting the anti-protease activity.
Heusipp G; Spekker K; Brast S; Fälker S; Schmidt MA
Microbiology (Reading); 2006 May; 152(Pt 5):1327-1335. PubMed ID: 16622050
[TBL] [Abstract][Full Text] [Related]
20. Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release.
Nita I; Hollander C; Westin U; Janciauskiene SM
Respir Res; 2005 Jan; 6(1):12. PubMed ID: 15683545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
